Status:
RECRUITING
MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
University of Basel
Conditions:
Acute Cardiovascular Disease
ST-segment Elevation Myocardial Infarction (STEMI)
Eligibility:
All Genders
18+ years
Brief Summary
The research project aims to develop clinical decision support tools integrating established diagnostic variables and machine learning (ML) models for rapid diagnosis of acute life-threatening cardiov...
Detailed Description
Current State of Research in the Field Acute cardiovascular disease (ACVD) is the leading cause of death in Switzerland and Europe, responsible for 29% of deaths in Switzerland and 36% across Europe....
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- • Acute cardiovascular disease (ACVD)
- Exclusion Criteria
- age \< 18 years old
- patients presenting in cardiogenic shock
- chronic terminal kidney failure requiring dialysis
Exclusion
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
200000 Patients enrolled
Trial Details
Trial ID
NCT06927791
Start Date
April 1 2024
End Date
March 1 2027
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031